Clinical Trial Update: LEVOS - Levofloxacin and Rifampicin Therapy in the Treatment of OsteoArticular Prothethic Infection [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating levofloxacin plus rifampicin for prosthetic joint infection has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prosthetic Joint Infection

Drugs mentioned

• Levofloxacin (Levofloxacin)
• Rifampicin

Snippet

Sponsor: Sanofi | Conditions: Infection | Phase 3 | Status: TERMINATED